Literature DB >> 20351669

Use of neck magnetic resonance venography, Doppler sonography and selective venography for diagnosis of chronic cerebrospinal venous insufficiency: a pilot study in multiple sclerosis patients and healthy controls.

D Hojnacki1, P Zamboni, A Lopez-Soriano, R Galleotti, E Menegatti, B Weinstock-Guttman, C Schirda, C Magnano, A M Malagoni, C Kennedy, I Bartolomei, F Salvi, R Zivadinov.   

Abstract

AIM: Chronic cerebrospinal venous insufficiency (CCSVI) is a vascular condition characterized by anomalies of primary veins outside the skull that restrict normal outflow of blood from the brain. CCSVI was recently described as highly prevalent in patients with multiple sclerosis (MS), and can be non-invasively diagnosed by Doppler sonography (DS) and invasively by selective venography (SV). The aim of this paper was to investigate the value of neck magnetic resonance venography (MRV) for the diagnosis of CCSVI compared to DS and SV in patients with MS and in healthy controls (HC).
METHODS: Ten MS patients and 7 HC underwent DS, 2D-Time-Of-Flight venography (TOF) and 3D-Time Resolved Imaging of Contrast Kinetics angiography (TRICKS). MS patients also underwent SV. The internal jugular veins (IJVs) and the vertebral veins (VVs) were assessed by both MRV sequences, and the findings were validated against SV and DS. SV has been considered the diagnostic gold standard for MS patients.
RESULTS: All MS patients and none of the HC presented CCSVI, according to the DS criteria. This was confirmed by SV. For CCSVI diagnosis, DS showed sensitivity, specificity, accuracy, PPV and NPV of 100%, whereas the figures were 40%, 85%, 58%, 80% and 50% for 3D-TRICKS, and 30%, 85%, 52%, 75% and 46% for 2D-TOF in the IJVs. In MS patients, compared to SV, DS showed sensitivity, specificity, accuracy, PPV and NPV of 100%, 75%, 95%, 94% and 100%, whereas the figures were 31%, 100%, 45%, 100% and 26% for 3D-TRICKS and 25%, 100%, 40%, 100% and 25% for 2D-TOF in the IJVs.
CONCLUSION: The use of MRV for diagnosis of CCSVI in MS patients has limited value, and the findings should be interpreted with caution and confirmed by other imaging techniques such as DS and SV.

Entities:  

Mesh:

Year:  2010        PMID: 20351669

Source DB:  PubMed          Journal:  Int Angiol        ISSN: 0392-9590            Impact factor:   2.789


  28 in total

1.  Unclear value of positional MR angiography in evaluating cerebral venous outflow hemodynamics.

Authors:  K Dolic; K Marr; R Zivadinov
Journal:  AJNR Am J Neuroradiol       Date:  2012-01-26       Impact factor: 3.825

2.  Chronic cerebrospinal venous insufficiency in multiple sclerosis: a historical perspective.

Authors:  Michael D Dake; Robert Zivadinov; E Mark Haacke
Journal:  Funct Neurol       Date:  2011 Oct-Dec

3.  Sensitivity and specificity for screening of chronic cerebrospinal venous insufficiency using a multimodal non-invasive imaging approach in patients with multiple sclerosis.

Authors:  K Dolic; K Marr; V Valnarov; M G Dwyer; E Carl; J Hagemeier; C Kennedy; C Brooks; C Kilanowski; K Hunt; D Hojnacki; B Weinstock-Guttman; R Zivadinov
Journal:  Funct Neurol       Date:  2011 Oct-Dec

4.  Comparison of MR and contrast venography of the cervical venous system in multiple sclerosis.

Authors:  G Zaharchuk; N J Fischbein; J Rosenberg; R J Herfkens; M D Dake
Journal:  AJNR Am J Neuroradiol       Date:  2011-07-14       Impact factor: 3.825

5.  Value of MR venography for detection of internal jugular vein anomalies in multiple sclerosis: a pilot longitudinal study.

Authors:  R Zivadinov; R Galeotti; D Hojnacki; E Menegatti; M G Dwyer; C Schirda; A M Malagoni; K Marr; C Kennedy; I Bartolomei; C Magnano; F Salvi; B Weinstock-Guttman; P Zamboni
Journal:  AJNR Am J Neuroradiol       Date:  2011-04-07       Impact factor: 3.825

6.  Percutaneous transluminal angioplasty for treatment of chronic cerebrospinal venous insufficiency (CCSVI) in people with multiple sclerosis.

Authors:  Vanitha A Jagannath; Eugenio Pucci; Govindaraj V Asokan; Edward W Robak
Journal:  Cochrane Database Syst Rev       Date:  2019-05-31

7.  Phlebographic study does not show differences between patients with MS and control subjects.

Authors:  M Stefanini; S Fabiano; F Garaci; S Marziali; A Meschini; V Cama; M Fornari; S Rossi; D Centonze; R Gandini; G Simonetti; R Floris
Journal:  AJNR Am J Neuroradiol       Date:  2014-02-13       Impact factor: 3.825

8.  Jugular Venous Flow Abnormalities in Multiple Sclerosis Patients Compared to Normal Controls.

Authors:  Sean K Sethi; David T Utriainen; Ana M Daugherty; Wei Feng; J Joseph Hewett; Naftali Raz; E Mark Haacke
Journal:  J Neuroimaging       Date:  2014-10-15       Impact factor: 2.486

9.  Extracranial Venous abnormalities: A true pathological finding in patients with multiple sclerosis or an anatomical variant?

Authors:  Carlos Torres; Matthew Hogan; Satya Patro; Santanu Chakraborty; Thanh Nguyen; Rebecca Thornhill; Mark Freedman; Miguel Bussiere; Hamid Dabirzadeh; Betty Anne Schwarz; Stefanie Belanger; Lysa Legault-Kingstone; Mark Schweitzer; Cheemun Lum
Journal:  Eur Radiol       Date:  2016-03-24       Impact factor: 5.315

10.  Cerebral vein changes in relapsing-remitting multiple sclerosis demonstrated by three-dimensional enhanced T₂-weighted angiography at 3.0 T.

Authors:  Chun Zeng; Xuan Chen; Yongmei Li; Yu Ouyang; Fajin Lv; Reshiana Rumzan; Zhongping Wang
Journal:  Eur Radiol       Date:  2012-09-12       Impact factor: 5.315

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.